Related Experiment Videos

Observations with trimethoprim tablet used in urinary tract infections

A Bécsi1

  • 1Department of Urology, Municipal István Hospital and Outpatient Clinic, Budapest.

Therapia Hungarica (English Edition)
|January 1, 1990
PubMed

Insights

Trimethoprim monotherapy effectively treated acute and chronic cystitis and urethritis, particularly for E. coli infections. While less effective for other bacteria, it showed minimal side effects in patients.

Area of Science:

  • Urology
  • Infectious Diseases
  • Pharmacology

Background:

  • Urinary tract infections (UTIs) are common, necessitating effective antimicrobial therapies.
  • Bacterial resistance and treatment efficacy are key concerns in managing UTIs.
  • Trimethoprim is an antibiotic frequently used for bacterial infections.

Purpose of the Study:

  • To evaluate the efficacy and safety of trimethoprim monotherapy in treating urinary tract infections.
  • To determine the effectiveness of trimethoprim against specific uropathogens, including E. coli.

Main Methods:

  • A cohort of 50 patients with UTIs received trimethoprim monotherapy.
  • Treatment outcomes were categorized as recovery, improvement, or no change.
  • Efficacy was assessed based on the causative microorganisms, focusing on E. coli.

Main Results:

  • 36% of patients achieved full recovery, while 30% showed improvement.
  • No significant change was observed in 34% of cases.
  • Trimethoprim demonstrated high efficacy against E. coli but was less effective against other Gram-negative and Gram-positive bacteria.

Conclusions:

  • Trimethoprim monotherapy is a viable treatment option for acute and chronic cystitis and urethritis, especially when caused by E. coli.
  • The drug is less effective for UTIs stemming from other bacterial species.
  • Trimethoprim exhibited a favorable safety profile with few observed side effects.

Related Concept Videos